The ICHS-Conference has been approved for a maximum of 16 CME points by “Ärztekammer Berlin”

Sunday 15 June 2014

12:30 – 19:00

Registration  Open

13:00 – 15:00

Satellite Symposium (Merck & Co.)

15:30 – 16:15

Opening Session – Plenary #1 (Georg Maschmeyer, Berlin & Tom Patterson, San Antonio)

Microbiome - Eric G. Pamer (New York)

16:30 - 18:30

Satellite Symposium (Pfizer)

19:00 - 20:00

Welcome Reception

Monday 16 June 2014

07:30 - 17:30

Registration open

08:00 - 09:00

Poster mounting

09:00 – 18:00

Poster exhibition open

08:00 – 09:00

Meet-the-Expert  Sessions

Meet the Expert #1: Jay A. Fishman (Boston) & Vicki A. Morrison (Minneapolis): Infections in transplant patients

Meet the Expert #2: Maria Elena Santolaya (Santiago de Chile) & Thomas Lehrnbecher (Frankfurt): Infections in Immunocompromised Children

Meet the Expert #3: Russell E. Lewis (Bologna) & Murat Akova (Ankara): Management of Multiresistant  Bacteria

09:15 – 10:00

Plenary Session #2

Chair: Claudio Viscoli (Genova) & Maria Elena Santolaya (Santiago)

Meeting the Challenges of Multidrug Resistance in Febrile Neutropenic Patients:  Lessons Learned from the Pioneers – Thomas J. Walsh (New York)

10:00 10:30

Coffee Break

10:30 – 12:30

Symposium #1 Neutropenic Fever Syndromes

Chair: Eric Bow (Manitoba) & Catherine Cordonnier (Creteil)

Risks Related to Neutropenic Fevers and Developing Complications - Eric J. Bow (Manitoba)

Febrile Mucositis and its Importance to the Practice of Oncology - Nicole A. Blijevens (Nijmegen)

Empirical Antibacterial Therapy in a Multi-Drug Resistant World - Murat Akova (Ankara)

Management of Severe Sepsis and Septic Shock Syndromes - Thierry Calandra (Lausanne)

10:30 – 12:30

Symposium #2 Measuring Immune Responses and Infectious Risk in ICH

Chairs: Jay A. Fishman (Boston) & Paolo A. Grossi (Varese)

Host Response to CMV:  Predictive Value – Petra Reinke (Berlin)

Host Response to BK Virus – Hans H. Hirsch (Basel)

Immunity in Fungal Infection:  Important Markers – Emmanuel Roiliades
(Thessaloniki)

Vaccination of the Immunocompromised Host – Markus Maeurer (Stockholm)

12:30 – 14:00

Satellite Symposium (Astellas)

14:00 – 14:30

Plenary Session #3

Chair: Carol Kauffman (Ann Arbor)

Pharmacokinetics of Antifungal Agents at Difficult Body Sites - Russell E. Lewis (Bologna)

14:45 – 16:15

Roundtable #1: Infections in Cancer Patients: Hot Topics in 2014

Joint Session ICHS & German AGIHO (ID Working Party of the German Society of Hematology and Medical Oncology) Chairs: Christina Rieger (Munich) and Helmut Ostermann (Munich)

Supported by an Unrestricted Educational Grant by Gilead Sciences

Bacteremia due to Multidrug-Resistant Gram-Negative Bacteria in Cancer Patients – Jordi Carratala (Barcelona)

Infection Control for Multidrug-Resistant Pathogens in Cancer Patients – Petra Gastmeier (Berlin)

Antiinfective Stewardship in Hematology/Oncology – Monica Slavin (Melbourne)

Role of an Antibacterial Prophylaxis in Hematology in the Era of Multidrug-Resistantce – Claudio Viscoli (Genoa)

14:45 – 16:15

Roundtable #2: Viral Infections in Transplant Recipients

Chairs: Per Ljungman (Stockholm) & Hans Hirsch (Basel)

Recent Developments in Antiviral Therapy - Michael Boeckh (Seattle)

Old and New Respiratory Viruses - Laurent Kaiser (Geneva)

Viral Hepatitis - Thomas Berg (Leipzig)

16:15 – 16:45

Plenary Session #4

Chairs: Michael Boeckh (Seattle) & Jay Fishman (Boston)

New Developments in CMV Vaccination - Paul Griffiths (London)

17:00 – 19:00

ICHS Member Meeting

19:30

Social Event at Restaurant ”Habel Weinkultur”

Tuesday 17 June 2014

07:30 – 17:00

Registration open

08:00 – 16:00

Poster exhibition open

08:00 – 09.00

Meet-the-Expert  sessions

Meet the Expert #4: Catherine Cordonnier (Creteil) & Russell E. Lewis (Bologna): Risk Stratification Models for Opportunistic Mycoses

Meet the Expert #5: Per Ljungman (Stockholm) & Clarisse Machado (São Paulo): Vaccinations in Immunocompromised Hosts

Meet the Expert #6: Monica Slavin (Melbourne) & Thomas F. Patterson (San Antonio): Complicated Infections in Cancer Patients

09:15 – 10:00

Plenary Session #5

Chairs: Monica Slavin (Melbourne) & Bob Finberg (Boston)

ICU in Critically Ill Neutropenic Cancer Patients - Eric J. Bow (Manitoba)

Who Should be Offered ICU? - Elie Azoulay (Paris)

10:00 10:30

Break

10:30 – 11:30

Slide Session: Best abstracts presentation

11:30 – 12:30

Plenary Session #6: Inflammasome and Host Response to Infection

Chairs: Clarisse Machado (Sao Paulo) & Tom Walsh (New York)

Inflammasome Activation and Regulation - Eicke Latz (Bonn)

Impact on Host Response - Robert W. Finberg (Boston)

12:30 – 14.00

Lunch and Poster Discussion (organized)

14:00 – 14:45

Plenary Session #7

Chairs: Tom Patterson (San Antonio) & Russ Lewis (Bologna)

Management of Breakthrough Fungal Infections in Patients on Systemic Antifungal Prophylaxis - Dimitrios P. Kontoyiannis (Houston)

15:00 – 17:00

Symposium #3:  Joint Symposium ICHS & ESCMID/SCGICH

Chairs: Murat Akova (Ankara) & Tom Patterson (San Antonio)

Recent Developments in Epidemiology, Diagnosis and Treatment of Pneumocystis - Jay A. Fishman (Boston)

Non-Culture Based Diagnosis of Invasive Fungal Disease – J. Peter Donnelly (Nijmegen)

Aspergillosis in ICU Patients: Epidemiology and Clinical Outcomes – Matteo Bassetti (Udine)

Galactomannan or PCR for Pre-Emptive Use of Antifungals in Hematology Patients? Jose M. Aguado (Madrid)

15:00 – 17:00

Symposium #4:  Unusual Infections in Unusual Hosts

Chairs: Dimitrios Kontoyiannis (Houston) & Oliver Cornely (Cologne)

Chronic Granulomatous Disease - Brahm H. Segal (Buffalo)

Collagen Vascular Diseases - Carol A. Kauffman (Michigan)

Premature Neonates - Emmanuel Roilides (Thessaloniki)

Existing Lung Disease – Paul A. Corris (Newcastle)

17.00

Farewell